Author:
Habibollahzadeh Negar,Yavari Samin,Mirazimi Yasin,Aghayan Amir Hossein,Davoudian Atefeh,Rafiee Mohammad
Abstract
Abstract
Introduction
The therapeutic method for many malignant and non-malignant diseases is hematopoietic stem cell transplantation (HSCT), but it is not always fully successful in all patients. Indeed, HSCT can be influenced by a variety of factors. Here we reviewed the effect of microRNAs (miRs) on HSCT-related outcomes, like survival, infections, relapse, engraftment, and so on, systematically.
Method
WOS, Scopus, PubMed, Google Scholar, and ProQuest databases were searched. The PRISMA guideline was performed, and 24 studies were included through quality assessment. Classified data extraction was done based on the type of disease.
Results
The systematic review identified 47 miRs effective on HSCT. The role of miRs as tumor suppressors or oncogenes is reported in acute myeloblastic and lymphoblastic leukemia patients undergoing HSCT due to their effects on overall or event-free survival. Additionally, relapse after HSCT in multiple myeloma is correlated with miRs expression. Also, recovery from post-autologous HSCT cytopenia or platelet and neutrophil engraftment can be influenced by miRs. We highlighted here reports on specific miRs.
Conclusion
We reported prognostic miRs for in-depth clinical management of the HSCT process and its outcomes. Also, miRs are introduced for the prevention of HSCT-related complications, and future studies are suggested to evaluate personalized medicine’s utilization of miRs in therapeutic methods like HSCT in neoplasia.
Funder
Zanjan University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Khaddour K, Hana CK, Mewawalla P. Hematopoietic stem cell transplantation. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023. StatPearls Publishing LLC.; 2023.
2. Bazinet A, Popradi G. A general practitioner’s guide to hematopoietic stem-cell transplantation. Curr Oncol. 2019;26(3):187–91.
3. Rafiee M, Farsani MA, Amiri V, Hajifathali A, Gharehbaghian A, Mohammadi MH. Circulatory miR-155 correlation with platelet and neutrophil recovery after autologous hematopoietic stem cell transplantation, a multivariate analysis. Int J Hematol. 2021;114(2):235–45.
4. Zhang GQ, Shi JL, Yang XR, Zhang XP, Zhang LX, Zhang JL et al. High expression of microRNA-500 is associated with poor prognosis in patients with acute myeloid leukemia receiving allogeneic hematopoietic stem cell transplantation. Oncol Lett.17(6):5815–20.
5. Fu L, Qi JL, Gao X, Zhang NH, Zhang HH, Wang R et al. High expression of miR-338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy. J Cell Physiol.234(11):20704–12.